Develops CAR immunotherapy treatments for autoimmune diseases and cancer through stem cell research and clinical applications.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
iCell Biotechnology is a clinical-stage biotechnology company specializing in the research and development of proprietary CAR immunotherapies targeting autoimmune diseases and cancer. The company focuses on stem cell and immune cell research, product development, manufacturing, and clinical applications.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
iCell Biotechnology Management Team
iCell Biotechnology Valuations & Financials
View real-time NPM data on iCell Biotechnology stock including daily iCell Biotechnology stock price estimates, valuation history, and historical share price information. Access iCell Biotechnology financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track iCell Biotechnology pricing across six independent market signals. Looking for private company due diligence data sources on iCell Biotechnology? Get in touch to learn more.
Similar Companies
like iCell Biotechnology
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Bulbs.com
Consumer
Specializes in commercial lighting solutions, offering a wide range of energy-efficient products and services to businesses.
Copper CRM
Enterprise Software
Provides CRM tools that integrate with Google Apps to automate sales tracking, organize contacts, and streamline customer relationships in Gmail.
Replicated
Enterprise Software
Platform enabling secure distribution and management of enterprise software across on-premises and air-gapped environments.
DeepScribe
Healthcare & Life Sciences
Transforms clinician-patient conversations into complete, autonomous SOAP notes to streamline documentation and enhance patient care.
Zed
Enterprise Software
Rapidly enabling real-time AI-powered code collaboration with high responsiveness and intelligent tool integration.
Lux Aeterna
Develops fully reusable satellite buses for scalable, reliable, and flexible space missions with rapid redeployment and payload retrieval.
DMI
AI & Machine Learning
Delivers precision-engineered parts to enhance performance and reliability in competitive racing.
Bear Robotics
AI & Machine Learning
Develops AI-powered self-driving robots that deliver food and assist staff in restaurants to improve efficiency and service.
FAQ
We have answers
iCell Biotechnology stock does not trade on public stock exchanges. iCell Biotechnology stock is considered a private security and you need to be an accredited investor to trade shares. To invest in iCell Biotechnology stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
iCell Biotechnology Stock does not trade on public stock exchanges. In order to sell iCell Biotechnology shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
iCell Biotechnology does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view iCell Biotechnology share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for iCell Biotechnology stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell iCell Biotechnology stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in iCell Biotechnology stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
iCell Biotechnology is a private company and has not had an IPO. There is currently no iCell Biotechnology IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to iCell Biotechnology IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
